Table 1.
Baseline characteristics of 108 patients before percutaneous transhepatic biliary drainage
| Characteristics | Value | |
|---|---|---|
| Age (years), mean (SD), n (%) | 61.7 ±10.9 | |
| > 70 years | 28 (25.9) | |
| ≤ 70 years | 80 (74.1) | |
| Sex, male/female | 72/36 | |
| ECOG performance status, n (%) | ||
| 1 | 18 (16.7) | |
| 2 | 50 (46.3) | |
| 3 | 26 (24.1) | |
| 4 | 14 (12.9) | |
| Tumour type, n (%) | ||
| Pancreatic carcinoma | 34 (31.5) | |
| Cholangiocarcinoma | 20 (18.5) | |
| Hepatocellular carcinoma | 20 (18.5) | |
| Digestive tract invasion | 11 (10.2) | |
| Gallbladder carcinoma | 9 (8.3) | |
| Lymph node metastasis | 8 (7.4) | |
| Other | 6 (5.6) | |
| Obstruction level, n (%) | ||
| Hilar | 27 (25) | |
| Non-hilar | 81 (75) | |
| Liver metastases, n (%) | ||
| Present | 35 (32.4) | |
| Absent | 73 (67.6) | |
| Serum bilirubin level prior to PTBD, n (%) | ||
| > 342 µmol/l | 43 (39.8) | |
| ≤ 342 µmol/l | 65 (61.2) | |
| Duration from onset of jaundice to PTBD, days, median (IQR) | 16 (8.5-23) | |
| Hospital stay, days, median (IQR) | 9 (4-17) | |
ECOG – Eastern Cooperative Oncology Group; PTBD – percutaneous transhepatic biliary drainage